Rhino Propels Federated AI into the Enterprise Tech Stack Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals”…
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals”…
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader…
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader…
MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters
Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to…
MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters
Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to…
Faron Pharmaceuticals Notice of Half-Year Financial Results
TURKU, Finland and BOSTON, Aug. 04, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd (AIM: FARN, First…
Faron Pharmaceuticals Notice of Half-Year Financial Results
TURKU, Finland and BOSTON, Aug. 04, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd (AIM: FARN, First…
Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
Completed single ascending dose (SAD) portion of Phase 1 trial evaluating OV329, a potential next-generation…
Recce Pharmaceuticals Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives
SYDNEY, Australia, Aug. 04, 2023 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q),…
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
— Actively enrolling patients in CHASE Phase 2b clinical trial of KPI-012 for the treatment…
Janus International Group Successfully Completes Debt Refinancing
TEMPLE, Ga.–(BUSINESS WIRE)–Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading provider…
Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or…
Wellfield Announces Acquisition of Interest in Bosonic, Inc. and Closing of Private Placements
Toronto, Ontario–(Newsfile Corp. – August 4, 2023) – Wellfield Technologies Inc. (TSXV: WFLD) (OTCQB: WFLDF)…
PlasCred Circular Innovations Inc. Completes Business Combination Transaction
Vancouver, British Columbia–(Newsfile Corp. – August 4, 2023) – PlasCred Circular Innovations Inc. (CSE: COVE)…
Datametrex Receives New P.O. for $375K
Toronto, Ontario–(Newsfile Corp. – August 4, 2023) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB:…
Therma Bright Provides Update on Venowave’s Permanent CPT/HCPCS Codes and United States Distribution Partners
Toronto, Ontario–(Newsfile Corp. – August 4, 2023) – Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF)…
Society Pass Inc (Nasdaq: SOPA) Announces Payments Partnership with 2C2P to Enhance the Online Shopping Experience in Southeast Asia
Singapore, Aug 4, 2023 – (ACN Newswire) – Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast…
GrafTech Reports Second Quarter 2023 Results
Solid Execution in a Challenging Environment Leads to Sequential Improvement in Key Metrics BROOKLYN HEIGHTS,…